|
|
 Previous Article | Table of Contents | Next Article 
Signaling Pathways Regulating CD44-Dependent Cytolysis in Natural Killer Cells
Giuseppe Sconocchia,
Julie A. Titus, and
David M. Segal
From the Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.
CD44 is a cytotoxic triggering molecule on activated, but not fresh natural killer (NK) cells. In the current study, metabolic pathways used in CD44-directed lysis (CD44DL) were examined using activated human NK cells as effectors. We found that CD44 expressed by activated NK cells was indistinguishable in isoform and molecular weight from CD44 on unactivated cells. However, de novo protein expression was required for the induction of CD44DL, suggesting that activated NK cells contain proteins not present in fresh NK cells that couple CD44 to the lytic machinery. Concanimycin A, a selective inhibitor of perforin-based cytolysis, totally blocked CD44DL, natural cytototoxicity, and antibody-dependent cell-mediated cytolysis (ADCC). Moreover, studies in which kinase inhibitors were added during the effector phase of lysis indicated that protein-tyrosine and ser/thr kinases were required for all three cytolytic activities and that protein kinase C played a nonessential role in lysis. By contrast, wortmannin totally inhibited CD44DL, but failed to block natural cytotoxicity and only partially blocked ADCC, suggesting that phosphatidylinositol 3-kinase (PI 3-kinase) is required at an early, receptor-specific stage of CD44DL. Finally, cytochalasin B enhanced CD44DL, but not ADCC, indicating that CD44DL is modulated by actin polymerization. Taken together, our data suggest that CD44 in NK cells interacts with proteins induced during interleukin-2 activation in a triggering pathway that induces perforin release, requires PI 3-kinase, and is modulated by the cytoskeleton.
Blood, Vol. 90 No. 2 (July 15), 1997:
pp. 716-725
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
R. J. McKallip, M. Fisher, Y. Do, A. K. Szakal, U. Gunthert, P. S. Nagarkatti, and M. Nagarkatti
Targeted Deletion of CD44v7 Exon Leads to Decreased Endothelial Cell Injury but Not Tumor Cell Killing Mediated by Interleukin-2-activated Cytolytic Lymphocytes
J. Biol. Chem.,
October 31, 2003;
278(44):
43818 - 43830.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. E. Mummert, D. Mummert, D. Edelbaum, F. Hui, H. Matsue, and A. Takashima
Synthesis and Surface Expression of Hyaluronan by Dendritic Cells and Its Potential Role in Antigen Presentation
J. Immunol.,
October 15, 2002;
169(8):
4322 - 4331.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. L. Blass, E. Pure, and C. A. Hunter
A Role for CD44 in the Production of IFN-{{gamma}} and Immunopathology During Infection with Toxoplasma gondii
J. Immunol.,
May 1, 2001;
166(9):
5726 - 5732.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Mallone, A. Funaro, M. Zubiaur, G. Baj, C. M. Ausiello, C. Tacchetti, J. Sancho, C. Grossi, and F. Malavasi
Signaling through CD38 induces NK cell activation
Int. Immunol.,
April 1, 2001;
13(4):
397 - 409.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Sconocchia, J. A. Titus, A. Mazzoni, A. Visintin, F. Pericle, S. W. Hicks, F. Malavasi, and D. M. Segal
CD38 Triggers Cytotoxic Responses in Activated Human Natural Killer Cells
Blood,
December 1, 1999;
94(11):
3864 - 3871.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Haegel-Kronenberger, H. de la Salle, A. Bohbot, F. Oberling, J.-P. Cazenave, and D. Hanau
Adhesive and/or Signaling Functions of CD44 Isoforms in Human Dendritic Cells
J. Immunol.,
October 15, 1998;
161(8):
3902 - 3911.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
